SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
92
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of U.S. Physical Therapy, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 30, 2017 – USPH

NEW YORK, April 06, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of U.S. Physical Therapy, Inc. ("U.S. Physical Therapy") (NYSE: USPH ) between May 8, 2014 and March 16, 2017 . You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more information go to:

http://www.zlk.com/pslra-sb/u-s-physical-therapy-inc?wire=3

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Company had a material weakness in its internal controls over accounting and financial reporting; (2) the Company improperly accounted for redeemable non-controlling interests of acquired partnerships in violation of Generally Accepted Accounting Principles (“GAAP”); (3) as a result, the Company’s financial statements for the years ended December 31, 2014 and 2015, and all quarters within 2014 and 2015, and the first three quarters of 2016 contained material errors; and (4) as a result of the foregoing, Defendants’ statements about U.S. Physical Therapy’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in U.S. Physical Therapy you have until May 30, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Device Transforms Golf Ball Pickup Experience

Updated Category News Views 451

Revolutionary Device Enhances Golf Ball Retrieval Inventors are always looking for ways to simplify tasks and improve our experiences. One innovative creator has unveiled a practical solution for golfers: the BALL PICK. This device addresses a common struggle faced by golfers at all skill levels – the hassle of bending down to pick up golf balls. Imagine a device that...

Continue Reading
HCSC Introduces Simplified Health Care Coverage Alternative

Updated Category News Views 321

HCSC Launches a New Streamlined Health Care Coverage Option Health Care Service Corporation (HCSC) is thrilled to announce a new health plan designed to simplify the healthcare experience for its members. This innovative option is aimed at individuals looking for a more straightforward way to handle their healthcare expenses. Simplified Monthly Billing with No Deductibles...

Continue Reading
Desvelados Mexican Cantina: A Flavorful New Gem in Town

Updated Category News Views 314

Desvelados Mexican Cantina Is Now Open In a vibrant celebration, Desvelados Mexican Cantina has opened its doors, bringing authentic Mexican flavors to the local dining scene. This lively cantina invites food lovers to indulge in an array of mouthwatering dishes, making it the perfect spot for gatherings with friends and family. Dining Experience at Desvelados Upon...

Continue Reading
Promising Results from Arcus Biosciences’ Casdatifan in Cancer Trials

Updated Category News Views 67

Groundbreaking Developments in Cancer Treatment Arcus Biosciences, Inc. (NYSE:RCUS), a leader in biopharmaceutical innovation, has recently presented compelling clinical data regarding their leading candidate, casdatifan, a HIF-2a inhibitor that shows outstanding promise in treating metastatic kidney cancer. The data was shared by Dr. Toni K. Choueiri at a significant...

Continue Reading
Understanding Options Movement in Johnson & Johnson Stock

Updated Category News Views 203

Key Insights on Johnson & Johnson Options Activity Investors are paying close attention to the options market for Johnson & Johnson (NYSE: JNJ), as recent activities indicate a bearish stance among high-profile investors. Understanding these movements can be valuable for retail traders looking to navigate the complexities of stock trading. Recent Options Trends Recently,...

Continue Reading